Raymond Tannous, MD
Research Profile
Research Interests:
As the principal investigator for the Children Oncology Group, I conduct clinical trials in all areas of pediatric oncology. Our studies include phase II and phase III clinical trials, as well as epidemiology and biology studies. Every aspect of pediatric oncology is practically included (therapeutic trials in childhood lymphocytic leukemia, non-lymphocytic leukemias, brain tumors, liver tumors, eye tumors, renal tumors, soft tissue sarcomas, fibrous tumors, and bone tumors). Non therapeutic studies include quality of life issues, epidemiology, tumor biology, and pharmacology. Between 40 and 109 studies are active at any given point. My personal emphasis is on renal tumors, fibrous tumors, brain tumors and leukemia.
|
|
In the area of palliative care, I am involved in the development of a unique outreach program for the delivery of palliative care to children in a rural setting through a state-wide network of health professionals. New modalities of palliative care will be investigated as well.
In the field of storage diseases, I conduct studies into the treatment of Gaucher’s disease, and participate in the international database for the study of its natural history.
Affiliations:
Model System:
Publications:
- Paulino AC, Bauman N, Simon JH, Nguyen TX, Ritchie JM, Tannous R.
Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation. Med Pediatr Oncol. 2003 Aug;41(2):118-22.
- Hutchinson RJ, Gaynon PS, Sather H, Bertolone SJ, Cooper HA, Tannous R, Wells LM, Heerema NA, Sailer S, Trigg ME; Children's Cancer Group/Children's Oncology Group. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.
J Clin Oncol. 2003 May 1;21(9):1790-7.
- Heath JA, Steinherz PG, Altman A, Sather H, Jhanwar S, Halpern S, Pieters R, Shah N, Steinherz L, Tannous R, Terry W, Trigg ME; Children's Cancer Group. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study. J Clin Oncol. 2003 Apr 15;21(8):1612-7.
|
